Evidence map›Paper›PMID 35067099›Full record

Trial reportStroke2022

Underutilization of Endovascular Therapy in Black Patients With Ischemic Stroke: An Analysis of State and Nationwide Cohorts.

Youngran Kim, Anjail Sharrief, Min Ji Kwak, Swapnil Khose, Rania Abdelkhaleq, Sergio Salazar-Marioni, Guo-Qiang Zhang, Sunil A Sheth

Abstract readClinical TrialMulticenter Study
In one paragraph

Trial report in Stroke, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Hospital Socioeconomic Status and Acute Stroke Treatment in the United States.Cerebrovascular diseases (Basel, Switzerland) · 2026
    Article
  3. Racial and ethnic disparities in access to acute stroke capabilities in California: Association with rurality and telestroke access.Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Advancing Health Equity in the Cardiovascular Device Life Cycle.Circulation. Cardiovascular quality and outcomes · 2025
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Racial and Ethnic Disparities in Stroke Reperfusion Therapy in the USA.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2023
    Review
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Youngran KimDepartment of Neurology (Y.K., A.S., S.K., R.A., S.S.-M., G.-Q.Z., S.A.S.), McGovern Medical School, The University of Texas Health Science Center at Houston.ORCID 0000-0002-2063-5017
Anjail SharriefDepartment of Neurology (Y.K., A.S., S.K., R.A., S.S.-M., G.-Q.Z., S.A.S.), McGovern Medical School, The University of Texas Health Science Center at Houston.
Min Ji KwakDepartment of Internal Medicine, (M.J.K.), McGovern Medical School, The University of Texas Health Science Center at Houston.ORCID 0000-0003-2778-3984
Swapnil KhoseDepartment of Neurology (Y.K., A.S., S.K., R.A., S.S.-M., G.-Q.Z., S.A.S.), McGovern Medical School, The University of Texas Health Science Center at Houston.ORCID 0000-0001-7614-3751
Rania AbdelkhaleqDepartment of Neurology (Y.K., A.S., S.K., R.A., S.S.-M., G.-Q.Z., S.A.S.), McGovern Medical School, The University of Texas Health Science Center at Houston.ORCID 0000-0001-9619-6105
Sergio Salazar-MarioniDepartment of Neurology (Y.K., A.S., S.K., R.A., S.S.-M., G.-Q.Z., S.A.S.), McGovern Medical School, The University of Texas Health Science Center at Houston.ORCID 0000-0002-2722-7542
Guo-Qiang ZhangDepartment of Neurology (Y.K., A.S., S.K., R.A., S.S.-M., G.-Q.Z., S.A.S.), McGovern Medical School, The University of Texas Health Science Center at Houston.
Sunil A ShethDepartment of Neurology (Y.K., A.S., S.K., R.A., S.S.-M., G.-Q.Z., S.A.S.), McGovern Medical School, The University of Texas Health Science Center at Houston.ORCID 0000-0003-0602-8509

Funding

Deep Learning Enabled Endovascular Stroke Therapy Screening in Community HospitalsR01NS121154 · NINDS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI GIANCARDO, LUCA, SHETH, SUNIL · 2021 to 2025
$2.2M
NINDS NIH HHS R01 NS121154
6 · The paper itself

Abstract

background and purposeEndovascular therapy (EVT) is a very effective treatment but relies on specialized capabilities that are not available in every hospital where acute ischemic stroke is treated. Here, we assess whether access to and utilization of this therapy has extended uniformly across racial and ethnic groups.

methodsWe conducted a retrospective, population-based study using the 2019 Texas Inpatient Public Use Data File. Acute ischemic stroke cases and EVT use were identified using the

resultsAmong 40 814 acute ischemic stroke cases in Texas in 2019, 54% were White, 17% Black, and 21% Hispanic. Black patients had similar admissions to EVT-performing hospitals and greater admissions to comprehensive stroke centers (CSCs) compared with White patients (EVT 62% versus 62%,

conclusionsWe found no evidence of disparity in presentation to EVT-performing hospitals or CSCs; however, lower rates of EVT were observed in Black patients.

Indexed as

Black or African AmericanEndovascular ProceduresAdolescentAdultAgedAged, 80 and overFemaleHumansIschemic StrokeMaleMiddle AgedRetrospective StudiesTexasTissue Plasminogen ActivatorPLAT protein, humanTissue Plasminogen Activatorendovascular proceduresethnicityhealthcare disparitiesischemic strokesocioeconomic factorsthrombectomytissue-type plasminogen activator

Identifiers

PMID35067099
PMCPMC8979555

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.